Large-scale testing (Phase 3)Ended earlyNCT00089141What this trial is testingMycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)Who this might be right forCancer Martin, Paul 151
Not applicableStudy completedNCT05260203What this trial is testingMargheRITA (Remote Intelligence for Therapeutic Adherence)Who this might be right forMultiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more Advice Pharma Group srl 124
Testing effectiveness (Phase 2)Study completedNCT00002673What this trial is testingImmunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center 30
Early research (Phase 1)Study completedNCT00003107What this trial is testingInterleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Indiana University
Early research (Phase 1)Study completedNCT00005092What this trial is testingChemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more M.D. Anderson Cancer Center 7
Very early researchLooking for participantsNCT06398457What this trial is testingDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesWho this might be right forHematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Not applicableLooking for participantsNCT07390071What this trial is testingMultimodal Telerehabilitation in Patients Undergoing CAR-T Cell ImmunotherapyWho this might be right forLymphomaMyelomaCytokine Release Syndrome+1 more University of Utah 40
Testing effectiveness (Phase 2)Study completedNCT02362035What this trial is testingACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic MalignanciesWho this might be right forFollicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more Acerta Pharma BV 161
Not applicableEnded earlyNCT00594308What this trial is testingIn-Vivo Activated T-Cell Depletion to Prevent GVHDWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more Indiana University 10
Not applicableStudy completedNCT01626547What this trial is testingBiosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and OncologyWho this might be right forChemotherapy-induced Symptomatic AnaemiaSolid TumoursMalignant Lymphomas+1 more Hospira, now a wholly owned subsidiary of Pfizer 291
Not applicableEnded earlyNCT00965861What this trial is testingSCRI Tissue Testing RegistryWho this might be right forMelanomaMyelodysplastic SyndromeMultiple Myeloma+1 more SCRI Development Innovations, LLC 20
Testing effectiveness (Phase 2)Study completedNCT01658241What this trial is testingPanobinostat Biological Correlates StudyWho this might be right forNodal LymphomaLymphoma With Cutaneous InvolvementLymphoma in Leukemic Phase+2 more Peter MacCallum Cancer Centre, Australia 30
Testing effectiveness (Phase 2)Study completedNCT00005854What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Testing effectiveness (Phase 2)Looking for participantsNCT03297606What this trial is testingCanadian Profiling and Targeted Agent Utilization Trial (CAPTUR)Who this might be right forLymphoma, Non-HodgkinMultiple MyelomaAdvanced Solid Tumors Canadian Cancer Trials Group 720
Testing effectiveness (Phase 2)Looking for participantsNCT06119685What this trial is testingIDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic CancersWho this might be right forNHLMultiple MyelomaBlood Cancer+4 more Indapta Therapeutics, INC. 128
Early research (Phase 1)UnknownNCT01619761What this trial is testingNK Cells in Cord Blood TransplantationWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more M.D. Anderson Cancer Center 13
Early research (Phase 1)Study completedNCT02992483What this trial is testingPhase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple MyelomaWho this might be right forMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma Novartis Pharmaceuticals 31
Testing effectiveness (Phase 2)Study completedNCT01018979What this trial is testingSafety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease PatientsWho this might be right forMultiple MyelomaNon-Hodgkin LymphomaHodgkin Disease GPCR Therapeutics, Inc. 19
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26